Vanderbilt Ingram Cancer Center
- Vanderbilt-Ingram Cancer Center's eight formal research programs focus on the discovery of new approaches for the diagnosis, prevention, and treatment of cancer. These active and collaborative research programs generate approximately $142 million in annual research support from public and private sources.
- Balko Lab: Led by Dr. Justin Balko, this laboratory is focused on improving treatment outcomes in breast cancer (particularly triple-negative breast cancer) as well as in other solid tumors through translational approaches.
- Ferrell Lab: Led by Dr. Brent Ferrell, te primary goal of this lab’s research is to improve our understanding of myeloid malignancies, particularly acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), by using single cell approaches for therapeutic discovery.
- Haake Cancer Lab: Dr. Scott Haake and his lab members are “explorers of kidney cancer and extracellular matrix biology,” leveraging science and discovery to improve the lives of kidney cancer patients.
- Hurley Lab: A prostate cancer research laboratory led by Dr. Paula Hurley
- Philip Lab: The overall goal of this laboratory, led by Dr. Mary Philip, is to understand how tumor-specific T cells become dysfunctional.
- Kimryn Rathmell Lab: This laboratory, directed by Dr. Kimryn Rathmell, is focused on understanding the underlying biology of renal cell carcinomas.
- Savona Lab: Led by Dr. Michael Savona, the Savona Laboratory focuses on hematopoiesis and the biology of myeloid diseases (including acute myeloid leukemia, myelodysplasia, myeloproliferative neoplasms, and MDS/MPN overlap syndromes).
- Zinkel Lab: Led by Dr. Sandra Zinkel, this lab studies how inflammation in the bone marrow microenvironment impacts blood diseases such as clonal hematopoiesis, bone marrow failure (myelodysplastic syndrome (MDS) and leukemia and how inhibiting inflammation impacts disease.